OOIR: Observatory of International Research

Papers

(The TQCC of Movement Disorders Clinical Practice is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
TikTok Tics: A Pandemic Within a Pandemic	91
Tics and TikTok: Functional Tics Spread Through Social Media	66
The Cholinergic Brain in Parkinson's Disease	55
Prevalence of Non‐Motor Symptoms and Non‐Motor Fluctuations in Parkinson's Disease Using the MDS‐NMS	52
Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's Disease	46
Challenges in Clinicogenetic Correlations: One Gene – Many Phenotypes	42
De Novo Movement Disorders and COVID‐19: Exploring the Interface	32
The Prevalence of Idiopathic or Inherited Isolated Dystonia: A Systematic Review and Meta‐Analysis	31
Neuroimaging Detectable Differences between Parkinson's Disease Motor Subtypes: A Systematic Review	31
Pragmatic Approach on Neuroimaging Techniques for the Differential Diagnosis of Parkinsonisms	30
α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis	29
Sex Differences in Huntington's Disease: Evaluating theEnroll‐HDDatabase	28
Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?	28
Eye Movement Disorders in Movement Disorders	28
Accuracy of Smartphone Video for Contactless Measurement of Hand Tremor Frequency	28
DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease	26
Disease Onset in Huntington's Disease: When Is the Conversion?	24
Milestones in Tremor Research: 10 Years Later	23
Task Force Consensus on Nosology and Cut‐Off Values for Axial Postural Abnormalities in Parkinsonism	23
Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID‐19 Outbreak	22
Systematic Review of Prevalence Studies of Progressive Supranuclear Palsy and Corticobasal Syndrome	21
Coronavirus Disease 2019 and Related Parkinsonism: The Clinical Evidence Thus Far	21
Factors Associated with Health‐Related Quality of Life in Late‐Stage Parkinson's Disease	21
Exploring Interrater Disagreement on Essential Tremor Using a Standardized Tremor Elements Assessment	20
Current Guidelines for Classifying and Diagnosing Cervical Dystonia: Empirical Evidence and Recommendations	19

Does the Country Make a Difference in Impulse Control Disorders? A Systematic Review	19
Gender Differences in the Prevalence of Parkinson's Disease	18
Outcome of Hospitalized Parkinson's Disease Patients with and without COVID‐19	17
Cardiac ¹⁸F‐Dopamine PET Distinguishes PD with Orthostatic Hypotension from Parkinsonian MSA	17
Progression in Parkinson's Disease: Variation in Motor and Non‐motor Symptoms Severity and Predictors of Decline in Cognition, Motor Function, Disability, and Health‐Related Quality of Life as Assesse	17
Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study	17
Level I PD‐MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia	17
Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's Disease	17
Myoclonus and COVID‐19: A Challenge for the Present, a Lesson for the Future	17
GPi‐DBS for KMT2B‐Associated Dystonia: Systematic Review and Meta‐Analysis	16
Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case–Control Study in an Australian Cohort	16
Defining Atypical Anxiety in Parkinson's Disease	16
Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging	15
Thyroid Disorders and Movement Disorders—A Systematic Review	15
Preoperative Levodopa Response and Deep Brain Stimulation Effects on Motor Outcomes in Parkinson's Disease: A Systematic Review	15
Challenges in Clinicogenetic Correlations: One Phenotype – Many Genes	14
Acute Post‐Infectious Cerebellar Ataxia Due to COVID‐19	14
Abnormal Saccadic Oscillations Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Encephalopathy and Ataxia	14
Psychiatric Comorbidities in Functional Movement Disorders: A Retrospective Cohort Study	14
Evaluation of Individualized Multi‐Disciplinary Inpatient Treatment for Functional Movement Disorders	14
Myoclonus‐Ataxia Syndromes: A Diagnostic Approach	13
Have We Forgotten What Tics Are? A Re‐Exploration of Tic Phenomenology in Youth with Primary Tics	13
Multidimensional Apathy: The Utility of the Dimensional Apathy Scale in Huntington's Disease	13
Current Knowledge on the Evolution of Care Partner Burden, Needs, and Coping in Parkinson's Disease	13
Clinical Features of Idiopathic Normal Pressure Hydrocephalus: Critical Review of Objective Findings	12
Apathy and Anxiety in De Novo Parkinson's Disease Predict the Severity of Motor Complications	12
Depression and Apathy across Different Variants of Progressive Supranuclear Palsy	11
Premonitory Urge and Tic Severity, Comorbidities, and Quality of Life in Chronic Tic Disorders	11
Soft Signs in Essential Tremor Plus: A Prospective Study	11
A Systematic Review of the Spectrum and Prevalence of Non‐Motor Symptoms in Adults with Hereditary Cerebellar Ataxias	11
Parkinson's Disease Medication Prescribing and Administration During Unplanned Hospital Admissions	11
Does Depression Contribute to the Bladder and Bowel Complaint in Parkinson's Disease Patients?	11
Co‐Occurrence of Apathy and Impulsivity in Progressive Supranuclear Palsy	11
Homer‐3 Antibody Disease: A Potentially Treatable MSA‐C Mimic	11
Characteristics and Outcomes of Parkinson's Disease Individuals Hospitalized with COVID‐19 in a New York City Hospital System	11
The Role of Levodopa Challenge in Predicting the Outcome of Subthalamic Deep Brain Stimulation	10
Prevention of Falls in Parkinson's Disease: Guidelines and Gaps	10
Task Specific Tremor Subsequently Developing into Parkinson's Disease: Case Series	10
Safety of Bilateral Staged Magnetic Resonance‐Guided Focused Ultrasound Thalamotomy for Essential Tremor	10
VPS13D: One Family, Same Mutations, Two Phenotypes	10
Theta Burst Deep Brain Stimulation in Movement Disorders	10
Tremor and Movement Slowness Are Two Unrelated Adverse Effects Induced by Valproate Intake	10
Parkinsonism in Genetic Neurodevelopmental Disorders: A Systematic Review	10
Dystonia and Myelopathy in a Case of Stress‐Induced Childhood‐Onset Neurodegeneration with Ataxia and Seizures (CONDSIAS)	10
Aggression Toward Others Misdiagnosed as Primary Tics	10
Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease	10
Characterization of Non‐Motor Fluctuations Using the Movement Disorder Society Non‐Motor Rating Scale	9
Another Twist in the Tale: Intrafamilial Phenotypic Heterogeneity in ANO3‐Related Dystonia	9
Telehealth Transdiagnostic Cognitive Behavioral Therapy for Depression in Parkinson's Disease: A Pilot Randomized Controlled Trial	9
Movement Disorders and Liver Disease	9

Factors Associated with Headache and Nausea During Magnetic Resonance–Guided Focused Ultrasound for Tremor	9
The Power of Musification: Sensor‐Based Music Feedback Improves Arm Swing in Parkinson's Disease	9
Clinical Profile and Treatment Outcomes of Hypermanganesemia with Dystonia 1 and 2 among 27 Indian Children	9
Driving with Tic Disorders: An International Survey of Lived Experiences	9
Spastic Paraplegia Type 7 and Movement Disorders: Beyond the Spastic Paraplegia	9
Neuropsychiatric Symptoms Are Associated with Dementia in Parkinson's Disease but Not Predictive of it	9
Possible EIF2AK2‐Associated Stress‐Related Neurological Decompensation with Combined Dystonia and Striatal Lesions	9
Movement Disorders Associated with Hypogonadism	9
Can Patients with Wilson's Disease Develop Copper Deficiency?	9
Laboratory‐Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study Group	9
Deep Brain Stimulation: When to Test Directional?	9
Surgical Management of Parkinson's Disease in the Elderly	9
Dream Content Predicts Motor and Cognitive Decline in Parkinson's Disease	9
Heterozygous EIF2AK2 Variant Causes Adolescence‐Onset Generalized Dystonia Partially Responsive to DBS	9
Lisdexamfetamine Therapy in Paroxysmal Non‐kinesigenic Dyskinesia Associated with the KCNMA1‐N999S Variant	9
Quantitative REM Sleep without Atonia in Parkinson's Disease and Essential Tremor	8
Beyond Typical Ataxia Telangiectasia: How to Identify the Ataxia Telangiectasia‐Like Disorders	8
Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease	8
Persistence of Facio‐Skeletal Myorhythmia During Sleep in anti‐IgLON5 Disease	8
Advanced‐Stage Parkinson's Disease: From Identification to Characterization Using a Nationwide Database	8
Quantitative Assessment of Response to Long‐Term Treatment with Intravenous Immunoglobulin in Patients with Stiff Person Syndrome	8
Tics and Tic‐like Phenomena—Old Questions on a Grand New Scale Invited Editorial on TikTok and Tics	8
Benefits and Risks of a Staged‐Bilateral VIM Versus Unilateral VIM DBS for Essential Tremor	8
Self‐Reported Barriers to Exercise and Factors Impacting Participation in Exercise in Patients with Parkinson's Disease	8
Urodynamic Evaluation in Multiple System Atrophy: A Retrospective Cohort Study	8
The Spectrum of Movement Disorders in Cases with Osmotic Demyelination Syndrome	8
Biallelic Loss‐of‐Function NDUFA12 Variants Cause a Wide Phenotypic Spectrum from Leigh/Leigh‐Like Syndrome to Isolated Optic Atrophy	8
Ethnic Disparities in Treatment of Chronic Pain in Individuals with Parkinson's Disease Living in the United Kingdom	8
Delineation of Apathy Subgroups in Parkinson's Disease: Differences in Clinical Presentation, Functional Ability, Health‐related Quality of Life, and Caregiver Burden	8
The Role of Focused Ultrasound in the Management of Movement Disorders: Insights after 5 Years of Experience	8
Reappearance of Symptoms after GPi‐DBS Discontinuation in Cervical Dystonia	8
Impulse Control Disorders in Parkinson's Disease: Has COVID‐19 Related Lockdown Been a Trigger?	8
Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study	8
The Efficacy and Safety of Pridopidine on Treatment of Patients with Huntington's Disease: A Systematic Review and Meta‐Analysis	7
Parkinsonism and Positive Dopamine Transporter Imaging in a Patient with a Novel KMT2B Variant	7
Bilateral Focused Ultrasound Pallidotomy for Parkinson‐Related Facial Dyskinesia—A Case Report	7
Assistive Devices for Personal Mobility in Parkinson's Disease: A Systematic Review of the Literature	7
Severe Early‐Onset Parkinsonian Syndrome Caused by PLA2G6 Heterozygous Variants	7
DYT‐TUBB4A (DYT4 Dystonia): Clinical Anthology of 11 Cases and Systematized Review	7
Successful Treatment of Levodopa/Carbidopa Intestinal Gel Associated “Biphasic‐like” Dyskinesia with Pallidal Deep Brain Stimulation	7
Detection of ATXN2 Expansions in an Exome Dataset: An Underdiagnosed Cause of Parkinsonism	7
A Placebo‐Controlled Study to Assess the Sensitivity of Finger Tapping to Medication Effects in Parkinson's Disease	7
Anti‐IgLON5 Disease with Isolated Hemichorea: A Case Report and Review of the Literature	7
Brittle Biballism‐Dystonia in a Pediatric Patient with GNAO1 Mutation Managed Using Pallidal Deep Brain Stimulation	7
Clinical Features, Neuroimaging, and Levodopa‐Responsiveness in Holmes' Tremor: A Video‐Based Case‐Series with a Review of the Literature	7
A Cross‐Sectional Comprehensive Assessment of the Profile and Burden of Non‐motor Symptoms in Relation to Motor Phenotype in the Nigeria Parkinson Disease Registry Cohort	7
The Effect of Education on Symptom Onset and Severity of Huntington's Disease	7
Sars‐Cov‐2 in a Patient with Acute Chorea: Innocent Bystander or Unexpected Actor?	7
Sporadic Fatal Insomnia Presenting with Initial Symptoms of Parkinsonism and Abnormal Dopamine Transporter Imaging	7
Biallelic PTRHD1 Frameshift Variants Associated with Intellectual Disability, Spasticity, and Parkinsonism	7
Geste Antagoniste Effects on Motor Performance in Dystonia—A Kinematic Study	7
Congenital Ichthyosis in a Case of Spinocerebellar Ataxia Type 34: A Novel Presentation for a Known Mutation	7
Clozapine Is Severely Underused in Parkinson's Disease Patients	7
Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson's Disease Dementia: A 36 Months Follow Up Study	7
Intermittent Apomorphine Use for off Period Rescue in Parkinson's Disease: A Pragmatic Review of over Three Decades of Clinical Experience	7
Braak's Unfinished Hypothesis: A Clinicopathological Case Report of α‐Synuclein Peripheral Neuropathy Preceding Parkinsonism by 20 Years	7
Novel Approach to Movement Disorder Society–Unified Parkinson's Disease Rating Scale Monitoring in Clinical Trials: Longitudinal Item Response Theory Models	6
Dystonia‐Deafness Syndrome: ACTB Pathogenic Variant in an Argentinean Family	6
Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's Disease	6
Spinocerebellar Ataxia 40: Another Etiology Underlying Essential Tremor Syndrome	6
Dystonia and Hereditary Motor Sensory Neuropathy 6B Due to SLC25A46 Gene Mutations	6
Beyond the Dopaminergic System: Lessons Learned from levodopa Resistant Symptoms in Parkinson's Disease	6
Tourette Syndrome and Driving	6
Scoping Review onADCY5‐Related Movement Disorders	6
Will Artificial Intelligence Outperform the Clinical Neurologist in the Near Future? Yes	6
Functional Tic‐Like Behaviors: A Common Comorbidity in Patients with Tourette Syndrome	6
Feasibility and Safety of Telerehabilitation for Physiotherapy Interventions in Movement Disorders Patients	6
Patients with Cognitive Impairment in Parkinson's Disease Benefit from Deep Brain Stimulation: A Case‐Control Study	6
Video Anthology of Movement Disorders Due to Infections in South Asia	6
Antiphospholipid‐Related Chorea: Two Case Reports and Role of Metabolic Imaging	6
Predicting Outcome in a Cohort of Isolated and Combined Dystonia within Probabilistic Brain Mapping	6
Hand Dexterity and Pyramidal Dysfunction in Friedreich Ataxia, A Finger Tapping Study	6
Do Patients with Progressive Supranuclear Palsy Have Episodic Memory Impairment? A Systematic Review	6
Abstracts	6
Patients with Cervical Dystonia Demonstrated Decreased Cognitive Abilities and Visual Planning Compared to Controls	6
The Gray Area of Freezing of Gait Annotation: A Guideline and Open‐Source Practical Tool	6
Multiculturalism: A Challenge for Cognitive Screeners in Parkinson's Disease	6
Genetic Movement Disorders Commonly Seen in Asians	6
Complex Movement Disorders in a Boy with PURA Syndrome	5
Morbidity Milestones Demonstrate Long Disability‐Free Survival in Parkinson's Disease Patients with Deep Brain Stimulation of the Subthalamic Nucleus	5

Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette Syndrome	5
Asymmetry of Tremor in Spinocerebellar Ataxia 12‐ Exception or Rule?	5
Effect of Levodopa and Environmental Setting on Gait and Turning Digital Markers Related to Falls in People with Parkinson's Disease	5
Glycine Receptor Antibody‐Associated Progressive Encephalomyelitis with Rigidity and Myoclonus (PERM) DuringSARS‐CoV‐2 Infection: a Video‐Case Report	5
Combining Device‐Aided Therapies in Parkinson's Disease: A Case Series and a Literature Review	5
Ventriculomegaly Is the First Brain Morphological Change in Prodromal Idiopathic Normal Pressure Hydrocephalus	5
Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit	5
Single‐Center Study of 103 Consecutive Parkinson's Disease Patients with Levodopa‐Carbidopa Intestinal Gel	5
Symptom‐Triggered Attention to Self as a Possible Trigger of Functional Comorbidity	5
CORE‐Myoclonus Syndrome: A Proposed Neurological Initial Manifestation of COVID‐19	5
¹²³I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms	5
Toward e‐Scales: Digital Administration of the International Parkinson and Movement Disorder Society Rating Scales	5
Efficacy of Dual‐Task Training in Patients with Parkinson's Disease: A Systematic Review with Meta‐Analysis	5
Are Virtual Objective Assessments of Fall‐Risk Feasible and Safe for People with Parkinson's Disease?	5
A Self‐Reported Clinical Tool Predicts Falls in People with Parkinson's Disease	5
Measurement Properties of Clinical Scales Rating the Severity of Blepharospasm: A Multicenter Observational Study	5
“Ear of the Lynx” Sign in Hereditary Spastic Paraparesis (HSP) 76	5
The Successful Three‐Year Outcome of Deep Brain Stimulation in Gaucher Disease Type 1 Associated Parkinson's Disease: A Case Report	5
Comparison of Pimavanserin Versus Quetiapine for Hospitalization and Mortality Risk Among Medicare Beneficiaries with Parkinson's Disease Psychosis	5
Essential Tremor and Essential Tremor Plus Are Essentially Similar Electrophysiologically	5
Does MDS‐UPDRS Provide Greater Sensitivity to Mild Disease than UPDRS in De Novo Parkinson's Disease?	5
Motor and Non‐motor Outcomes of Deep Brain Stimulation across the Genetic Panorama of Parkinson's Disease: A Multi‐Scale Meta‐Analysis	5
Cognitive and Motor Decline in Dementia with Lewy Bodies and Parkinson's Disease Dementia	5
Clinical and Imaging Profile of Patients with Palatal Tremor	5
The Influence of GBA and LRRK2 on Mood Disorders in Parkinson's Disease	5
Clinicoradiological Features in Progressive Supranuclear Palsy Comorbid with Argyrophilic Grains	5
Functional Movement Disorders and Deep Brain Stimulation: A Multi‐Center Study	5
Continuous Subcutaneous Apomorphine Infusion before Subthalamic Deep Brain Stimulation: A Prospective, Comparative Study in 20 Patients	5
Cardiac Involvement in Movement Disorders	5
How Is Functional Neurological Disorder Managed in Australian Hospitals? A Multi‐Site Study Conducted on Acute Inpatient and Inpatient Rehabilitation Wards	5
Apraxia of Lid Opening in Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease—Frequency, Risk Factors and Response to Treatment	5
PHARC Syndrome, a Rare Genetic Disorder—Case Report	5
An Open‐Label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel in Cervical Dystonia	5
Intraventricular Baclofen Following Deep Brain Stimulation in a Child with Refractory Status Dystonicus	5
Subthalamic Nucleus Stimulation in Parkinson's Disease: 5‐Year Extension Study of a Randomized Trial	5
Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No	5
Longitudinal Follow‐Up of Mood in Cervical Dystonia and Influence on Age at Onset	5
Continuous Subcutaneous Infusion Delivery of Apomorphine in Parkinson's Disease: A Systematic Review	5
Good Response to Deep Brain Stimulation in Two Forms of Inherited Chorea Related to GNAO1 and Neuroacanthocystosis with Illustrative Videos	5
Abstracts	5
Life‐Space Mobility and Parkinson's Disease. A Multiple‐Methods Study	5
Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease	5
10 Years Follow‐Up of Deep Brain Stimulation in the Caudal Zona Incerta/Posterior Subthalamic Area for Essential Tremor	5
The “Hot Cross Bun Sign” in Spinocerebellar Ataxia Types 2 and 7–Case Reports and Review of Literature	5
Prevalence and Risk Factors for Double Vision in Parkinson Disease	5
Punding in Parkinson's Disease: An Update	5
The Challenge of Choosing the Right Stimulation Target for Dystonic Tremor—A Series of Instructive Cases	5
Determining the Validity of Conducting Rating Scales in Friedreich Ataxia through Video	5
Sudden Onset, Fixed Dystonia and Acute Peripheral Trauma as Diagnostic Clues for Functional Dystonia	5
An Eye on Movement Disorders	4
Comparison of Ultrasound and Electrical Stimulation Guidance for Onabotulinum Toxin‐A Injections: A Randomized Crossover Study	4
Meta‐analysis of Association between Newer Glucose‐Lowering Drugs and Risk of Parkinson's Disease	4
Impaired Touchscreen Skills in Parkinson's Disease and Effects of Medication	4
Fever‐Induced and Early Morning Paroxysmal Dyskinesia in a Man With GNB1 Encephalopathy	4
Recurrent Biallelic p.L347P PINK1 Variant in Polynesians with Parkinsonism and Isolated Dopa‐Responsive Dystonia	4
Hereditary Spastic Paraplegia 7 Presenting as Multifocal Dystonia with Prominent Cranio‐Cervical Involvement	4
Social Cognition in Parkinson's Disease: A Case‐Control Study	4
β‐Blocker–Induced Tremor	4
Post–COVID‐19 Myoclonus–Ataxia Syndrome Responsive to Intravenous Immunoglobulins	4
Advanced Therapies for the Management of Dopamine Dysregulation Syndrome in Parkinson's Disease	4
The Hot Cross Bun Sign: A Journey Across Etiologies	4
Obstructive Sleep Apnea and Other Vascular Risk factors' Impact on Non‐Motor Symptoms in Parkinson's Disease	4
Parkinson's Disease with a Homozygous PARK7 Mutation and Clinical Onset at the Age of 5 Years	4
What Is the Most Important and Impactful Paper Related to Movement Disorder Therapy Published in the 20th Century?	4
Driving Impairment in Movement Disorders	4
The Rush Video‐Based Tic Rating Scale‐Revised: A Practice‐Oriented Revision	4
Neurodevelopmental Disorder and Late‐Onset Degenerative Parkinsonism in a Patient with a WDR45 Defect	4
Levodopa‐Entacapone‐Carbidopa Intestinal Gel Treatment in Advanced Parkinson's Disease: A Single‐Center Study of 30 Patients	4
Montreal Cognitive Assessment Predicts the Short‐Term Risk of Lewy Body Disease in Isolated REM Sleep Behavior Disorder with Reduced MIBG Scintigraphy	4
Impact of Intestinal Bacteria on Levodopa Pharmacokinetics in LCIG Therapy	4
Brain Bank Questionnaire Helps in Differential Diagnosis of Movement Disorders: An Autopsy Study of 150 Patients	4
Association of Concurrent Olfactory Dysfunction and Probable Rapid Eye Movement Sleep Behavior Disorder with Early Parkinson's Disease Progression	4
Movement Disorders and the Gut: A Review	4
Skin Conditions and Movement Disorders: Hiding in Plain Sight	4
Reckless Generosity, Parkinson's Disease and Dopamine: A Case Series and Literature Review	4
Myoclonus‐Dystonia Presentation of ATM Gene Mutation in a Canadian Mennonite	4
Telemonitoring via Questionnaires Reduces Outpatient Healthcare Consumption in Parkinson's Disease	4
Late‐Onset Chorea in JAK2‐Associated Essential Thrombocythemia	4
Patients' Postjudice of Tele‐Neurology for Movement Disorders	4
Expert Consensus on the Use of On‐Demand Treatments for OFF Episodes in Parkinson's Disease: A Modified Delphi Panel	4
Is Pathology Always the Diagnostic Gold Standard in Neurodegeneration?	4
Cerebellar Syndrome Induced by Hypomagnesemia: A Treatable Cause of Ataxia Not to be Missed. Report of Three Cases and a Review of the Literature	4
Movement Disorders and Hematologic Diseases	4
Movement Disorders and Musculoskeletal System: A Reciprocal Relationship	4
MPTP Parkinsonism and Implications for Understanding Parkinson's Disease	4
Central Cognitive Processing Speed Is an Early Marker of Huntington's Disease Onset	4
Safety and Efficacy of Long‐Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open‐Label Extension Study	4
Demographics and Clinical Characteristics of Autosomal Dominant Spinocerebellar Ataxia in Canada	4
From Collar to Coccyx: Truncal Movement Disorders: A Clinical Review	4
Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's Disease	4
A Case of MPAN with “Eye of the Tiger Sign,” Mimicking PKAN	4
Reconstructing Re‐emergent Tremor	3
Anderson‐Fabry Disease: A Rare Cause of Levodopa‐Responsive Early‐Onset Parkinsonism	3
Hemimasticatory Spasm: The First Case Report of Bilateral Presentation	3
Outcomes of an Integrated Multidisciplinary Clinic for People with Functional Neurological Disorder	3